¿´Æ¬ÊÓƵ

HBHL Governance

Graph showing governance hierarchy. Oversight is led by the Board of Directors and the Strategic Steering Committee, and oversees the Management (Scientific Director and the Managing Director & CEO) and the Guidance (All other committees and councils)


ÌýBoard of Directors

  • Vice-President, Research and Innovation, Dominique BérubéÌý(Chair)
  • Provost and Vice-PresidentÌý(Academic), Christopher Manfredi (Co-Chair)
  • Vice-President, Administration and Finance, Fabrice Labeau
  • Acting Vice-PresidentÌýResearch, Western University, Penny Pexman
  • Director, Montreal Neurological Institute and Hospital, Guy Rouleau
  • Vice-PresidentÌý(Health Affairs) and Dean of Medicine and Health Sciences, Lesley Fellows
  • Dean of Science, Bruce Lennox
  • Delegate for the Dean of Arts, MichaelÌýBloom-Tillmann
  • Member-at-large, Robert Dunlop (Past Assistant Deputy Minister with Industry Canada)
  • Member-at-large, Jane Roskams (University of British Columbia)
  • HBHL Scientific Director, Alan Evans (non-voting)
  • HBHL Managing Director & CEO,ÌýKrystle van HoofÌý(non-voting)


See Terms of ReferenceÌýfor the Board of Directors.

Strategic Steering Committee

  • Vice-President, Research and Innovation,ÌýDominique BérubéÌý(Chair)
  • HBHL Scientific Director, Alan Evans (Co-Chair)
  • HBHL Associate Scientific Director, Doina Precup
  • Assistant Vice-President, Research and Innovation, Kristina Öhrvall
  • Acting Associate Provost, Academic Policies and Faculty Affairs, David Wright
  • Vice Dean of the Faculty of Medicine and Health Sciences, Shari Baum
  • Director of the Douglas, Gustavo Turecki
  • Director of the Neuro (delegate), Edward Fon
  • Scientific director of University of Montreal's CFREF Initiative, Yves Joanette
  • External Member-at-large, Marco Blouin (MEI)
  • External Member-at-large, Elizabeth Douville (Amorchem)
  • HBHL Managing Director & CEO, Krystle van Hoof (non-voting)


See Terms of Reference for the Strategic Steering Committee.Ìý

Equity, Diversity and Inclusion Committee

  • Faculty Member-at-large,ÌýXiaoqian Chai (EDI Co-Chair)
  • Core Member of the HBHL Research Management Committee,ÌýThomas Durcan (EDI Co-Chair)
  • Senior Research Equity Advisor,ÌýUzma Jamil
  • Member of HBHL Leadership,ÌýMartin Lepage
  • Member of HBHL Leadership, Jean-Baptiste Poline
  • Faculty Member-at-large, Jesper Sjöström
  • HBHL Affiliated Trainee, Lyne Baaj
  • HBHL Affiliated Trainee, Ethan Draper
  • HBHL Affiliated Trainee, Eden Redman
  • HBHL Managing Director & CEO (non-voting), Krystle van Hoof


See Terms of Reference for the Equity, Diversity and Inclusion Committee.

Research Management Committee

  • HBHL Scientific Director,ÌýAlan Evans (Chair)
  • HBHL Associate Scientific Director, Doina PrecupÌý(Co-Chair)
  • HBHL Theme 1 Leader, Blake Richards
  • HBHL Theme 2 Leader, SylviaÌýVilleneuve
  • HBHL Theme 3 Leader, Madeleine Sharp
  • HBHL Theme 4 Leader, Martin Lepage
  • HBHL Associate Theme 1 Leader, Boris Bernhardt
  • HBHL Associate Theme 2 Leader, Jean-Francois Poulin
  • HBHL Associate Theme 3 Leader, Nathan Spreng
  • HBHL Associate Theme 4 Leader, Jai Shah
  • Canadian Framework for Brain Health Chair, Laurence Kirmayer
  • Core Facility Leader, Mark Brandon
  • Core Facility Leader, (Currently vacant)
  • EDI Chair, Thomas Durcan
  • NeuroHub representative, Jean-Baptiste Poline
  • Member-at-large (external), (Currently vacant)
  • Member-at-large (external), (Currently vacant)
  • Community Member-at-large, Alexandre Reynaud
  • Community Member-at-large, (Currently vacant)
  • HBHL Managing Director & CEO (non-voting),ÌýKrystle van Hoof


See Terms of Reference for the Research Management Committee.

Innovation Committee

  • Associate Vice-President, Innovation and Partnership,ÌýBenoit Boulet (Chair)
  • Director, Innovation and Partnerships, Mark Weber
  • Faculty of Medicine and Health SciencesÌýRepresentative, Etienne de Villers-Sidani
  • Member-at-large, Helen Loughrey (Investment Advisor)
  • Member-at-large, François BergeronÌý(VP Partnerships, MEDTEQ+)
  • Member-at-large, Nathalia del Moral Fleury
  • Member-at-large, Francine Gervais (Consultant)
  • Academic Director at the Dobson Centre, Marie Josee Lamothe
  • Representative from The Neuro, Annabel Seyller
  • Representative from The Douglas, Salah El Mestikawy
  • HBHL Associate Director Business DevelopmentÌý(non-voting),ÌýAdrienne Crampton
  • HBHL Managing Director & CEO (non-voting),ÌýKrystle van Hoof


See Terms of Reference for the Innovation Committee.

International Advisory Council

  • Katrin Amunts, University of Düsseldorf
  • Paul Thompson, University of Southern California
  • Pedro Valdes Sosa, Cuban Neurosciences Center
  • Richard Wade-Martins, University of Oxford
  • Carol Worthman, Emory University


See Terms of Reference for the International Advisory Council.

Training Program Committee

  • Dean of Graduate and Postdoctoral Studies, Josephine NalbantogluÌý(Chair)
  • Associate Dean, Biomedical BSc, Graduate and Postdoctoral Affairs, Aimee Ryan
  • Co-President of the HBHL Trainee Committee, (Currently vacant)
  • Co-President of the HBHL Trainee Committee, (Currently vacant)
  • HBHL Managing Director & CEO (non-voting), Krystle van Hoof


See Terms of Reference for the Training Program Committee.

Canadian Framework for Brain Health Research (CFBHR) Steering Committee

  • Laurence Kirmayer, Co-Chair
  • Lucyna Lach, Co-Chair
  • Boris Bernhardt, Associate Theme 1 LeaderÌý
  • Jai Shah, Associate Theme 4 Leader
  • Madeleine Sharp, ¿´Æ¬ÊÓƵ community Member
  • Jean-Baptiste Poline, ¿´Æ¬ÊÓƵ Community Member
  • Tim Evans, ¿´Æ¬ÊÓƵ Community Member
  • Amélie Quesnel-Vallée, ¿´Æ¬ÊÓƵ Community Member
  • Robert-Paul Juster, External Member
  • Mark Daley,ÌýExternal Member


See Terms of Reference for the Canadian Framework for Brain Health Research (CFBHR) Steering Committee

Back to top